df176ce612
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
3.1 KiB
3.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Relates to the New York state adult cystic fibrosis program | Establishes the New York state adult cystic fibrosis program which consists of administrative support services for the provision of financial assistance for services such as prescription drug costs, device costs, medical care services, behavioral health services, and insurance premiums for the treatment of cystic fibrosis disease and its conditions. | us/states/ny | New York Legislature | 2023-2024 | A 8515 | New York A 8515 (2023-2024) |
|
enacted |
|
1 | 15 | 2 | 2024-01-04 | 2024-02-07 | openstates | ocd-bill/ee3085ed-3aa4-43e6-a4ce-dda4ebf4f4c8 | http://www.nysenate.gov/legislation/bills/2023/A8515 | 64050a2fcc31d6f5fef7b4c34a96269031eef40e7a2a9e814676851acd1a389b | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
New York A 8515 (2023-2024) — Relates to the New York state adult cystic fibrosis program
Establishes the New York state adult cystic fibrosis program which consists of administrative support services for the provision of financial assistance for services such as prescription drug costs, device costs, medical care services, behavioral health services, and insurance premiums for the treatment of cystic fibrosis disease and its conditions.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- A8515 (committee substitute) — source
Votes
- Assembly Vote — 143–5 (pass) · lower
- Floor Vote — 60–0 (pass) · upper
Sponsors
- Stacey Pheffer Amato — primary (person)
- Aileen Gunther — cosponsor (person)
- Nader Sayegh — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2024-01-04 REFERRED TO HEALTH
referral-committee - 2024-01-17 REPORTED REFERRED TO WAYS AND MEANS
referral-committee - 2024-01-22 REPORTED REFERRED TO RULES
referral-committee - 2024-01-22 REPORTED
- 2024-01-22 RULES REPORT CAL.5
- 2024-01-22 ORDERED TO THIRD READING RULES CAL.5
- 2024-01-23 PASSED ASSEMBLY
passage - 2024-01-23 DELIVERED TO SENATE
- 2024-01-23 REFERRED TO RULES
referral-committee - 2024-01-24 SUBSTITUTED FOR S8002
- 2024-01-24 3RD READING CAL.11
- 2024-01-24 PASSED SENATE
passage - 2024-01-24 RETURNED TO ASSEMBLY
- 2024-02-07 DELIVERED TO GOVERNOR
executive-receipt - 2024-02-07 SIGNED CHAP.31
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/ee3085ed-3aa4-43e6-a4ce-dda4ebf4f4c8. Confidence: reported (aggregated from official New York legislature records).